Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 32 of 32 entries
View as:

A Trial With TMC278-TIDP6-C222 for Continued TMC278 Access in Patients Infected With Human Immunodeficiency Virus-1

Phase: N/A Priority: Normal
NCT ID: NCT01266902 Org: User:
Start: 02/28/11 End: 02/29/20 Due: 02/28/21

A Study to Investigate the Safety, Tolerability and Pharmacokinetics of GSK2336805 Alone and With the Co-administration of TMC435 in Healthy Japanese Participants.

Phase: N/A Priority: Normal
NCT ID: NCT02018536 Org: User:
Start: 10/31/13 End: 03/31/14 Due: 03/31/15

A Study to Assess the Safety, Tolerability and Efficacy of TMC435 Along With Pegylated Interferon Alpha-2a (Pegasys) and Ribavirin (Copegus) Triple Therapy in Chronic Hepatitis C Genotype-1 Infected Patients Co-infected With Human Immunodeficiency Virus-Type 1

Phase: N/A Priority: Normal
NCT ID: NCT01479868 Org: User:
Start: 10/31/11 End: 08/31/13 Due: 08/31/14

A Study in Japanese Children Hospitalized With Respiratory Syncytial Virus Related Lower Respiratory Tract Infections

Phase: N/A Priority: Normal
NCT ID: NCT02132923 Org: User:
Start: 12/31/13 End: 01/31/15 Due: 01/31/16

3-year Follow-up Study in Patients Previously Treated With TMC435-Containing Regimen for the Treatment of Hepatitis C Virus Infection

Phase: N/A Priority: Normal
NCT ID: NCT01349465 Org: User:
Start: 07/04/11 End: 01/05/16 Due: 01/05/17

Efficacy and Safety Study of Simeprevir in Combination With Sofosbuvir in Subjects With Chronic Genotype 4 Hepatitis C Virus Infection

Phase: N/A Priority: Normal
NCT ID: NCT02250807 Org: User:
Start: 01/31/15 End: 12/31/15 Due: 12/31/16

A Study in Healthy Participants Investigating the Safety, Tolerability and Plasma Pharmacokinetics (PK) of Single Oral Doses of JNJ-47910382

Phase: N/A Priority: Normal
NCT ID: NCT01482611 Org: User:
Start: 11/30/11 End: 04/30/12 Due: 04/30/13